Ambiq Micro (NYSE:AMBQ) Releases Earnings Results, Beats Expectations By $0.17 EPS

Ambiq Micro (NYSE:AMBQ) posted its quarterly earnings results on Tuesday. The company reported ($0.24) EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.17, Zacks reports. Ambiq Micro had a negative return on equity of 45.10% and a negative net margin of 46.86%. Ambiq Micro updated its Q3 2026 guidance to -0.200–0.120 EPS.

Here are the key takeaways from Ambiq Micro’s conference call:

• Second-quarter sales reached $33.9 million, up 89.7% year over year and ahead of guidance, while non-GAAP gross profit more than doubled and gross margin improved to 47.2%.
• Management raised its full-year 2026 sales outlook to approximately $135 million and expects third-quarter revenue of $36 million-$37 million, supported by accelerating edge-AI demand and continued customer product ramps.
• Demand is exceeding available capacity across wafers, packaging, substrates, and testing, constraining second-half revenue; management is seeking additional foundry and OSAT capacity, with some demand deferred until supply improves.
• Ambiq reported strong momentum for new Apollo3 Blue Plus and Apollo510 Lite products, broader adoption in medical, industrial, and smart-home markets, and continued development of Atomiq 110 and Apollo 340, targeted for customer sampling in early 2027.
• The company ended the quarter with $366.8 million in cash and no debt after raising roughly $168 million in its latest offering, but it plans to continue investing heavily in product development, including $7 million-$10 million of 2026 IP purchases, and did not provide a timeline for profitability or cash-flow breakeven.

Ambiq Micro Stock Performance

Shares of NYSE AMBQ traded down $0.25 during midday trading on Tuesday, reaching $63.67. The company’s stock had a trading volume of 133,649 shares, compared to its average volume of 507,851. The company has a market cap of $1.36 billion and a P/E ratio of -3.07. The business’s 50 day moving average price is $77.59 and its two-hundred day moving average price is $52.02. Ambiq Micro has a fifty-two week low of $22.12 and a fifty-two week high of $91.61.

Insider Activity

In other Ambiq Micro news, COO Sean Chihhsiang Chen sold 55,685 shares of Ambiq Micro stock in a transaction on Friday, May 15th. The stock was sold at an average price of $70.89, for a total value of $3,947,509.65. Following the completion of the transaction, the chief operating officer directly owned 120,275 shares of the company’s stock, valued at $8,526,294.75. The trade was a 31.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jeffrey G. Winzeler sold 26,000 shares of the stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $69.90, for a total value of $1,817,400.00. Following the sale, the chief financial officer directly owned 94,395 shares in the company, valued at approximately $6,598,210.50. This trade represents a 21.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 222,477 shares of company stock worth $16,304,893. 10.00% of the stock is currently owned by insiders.

Institutional Trading of Ambiq Micro

Several large investors have recently made changes to their positions in the company. BNP Paribas Financial Markets acquired a new position in Ambiq Micro during the third quarter valued at approximately $28,000. New York State Common Retirement Fund acquired a new position in shares of Ambiq Micro during the 4th quarter worth $48,000. JPMorgan Chase & Co. bought a new stake in shares of Ambiq Micro during the 3rd quarter worth $56,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Ambiq Micro during the 3rd quarter worth $65,000. Finally, Rhumbline Advisers acquired a new stake in Ambiq Micro in the third quarter valued at about $119,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Needham & Company LLC increased their price objective on shares of Ambiq Micro from $48.00 to $70.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Northland Securities set a $86.00 price target on shares of Ambiq Micro in a report on Wednesday, July 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Ambiq Micro in a research report on Monday, June 29th. UBS Group boosted their price objective on Ambiq Micro from $43.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Finally, Roth Capital initiated coverage on Ambiq Micro in a research report on Monday, July 13th. They issued a “buy” rating and a $125.00 target price on the stock. Four research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $71.83.

About Ambiq Micro

Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.